Analystreport

Seelos Therapeutics, Inc. (NASDAQ: SEEL) had its price target lowered by analysts at Benchmark Co. from $4.00 to $1.00.

Seelos Therapeutics, Inc.  (SEEL) 
Last seelos therapeutics, inc. earnings: 5/21 05:12 pm Check Earnings Report